×
Back to Agenda
Broadening Health Care Communications: Learnings from Health Authority Initiatives
Session Chair(s)
Stacey Fung, PHARMD
Head, Global Medical Information, Gilead Sciences, United States
The FDA and Innovative Collaborations to Broaden the Reach of Health Care Messages to the Public
Learning Objective : Describe innovative collaboration models with FDA for communicating information; Discuss how patients participate on the review of product information and communications produced by the EMA; Identify available information expanded access programs including ways forthe pharmaceutical industry to share this information with patients and health care providers.
Speaker(s)
Anna Fine, PHARMD, MS
Interim Director for ClinicalTrials.gov, National Institutes of Health (NIH), United States
The FDA and Innovative Collaborations to Broaden the Reach of Health Care Messages to the Public
Julia Petses, PHARMD
Global Head, Medical Information Excellence and SEC Established and Rare Franchi, Novartis, United States
Industry Perspective
Martin Harvey Allchurch, LLM
Head of International Affairs, European Medicines Agency, Netherlands
EMA Perspective on Communicating Health Care Messages to the Public
Have an account?